Skip to main content
. 2019 May 27;12:743–759. doi: 10.2147/DMSO.S182953

Table 1.

Variables determined from the hyper-insulinemic euglycemic clamp procedure

Variable, units of measurement Total number of subjects Pre-roflumilast, mean (SE) Post-roflumilast, mean (SE) P-value
Fasting plasma glucose, mg/dL 7 100.7 (3.4) 100.5 (2.7) 0.94*
Fasting plasma insulin, mcU/mL 6 20.6 (7.9) 27.3 (13.4) 0.46*
Basal hepatic glucose production, mg/kg lean mass/minute 7 2.45 (0.13) 2.78 (0.22) 0.10
Hepatic insulin resistance index 6 47.7 (15.7) 68.4 (27.7) 0.35*
Mean M value, mg/g fat free mass/minute 7 48.7 (10.4) 70.0 (20.1) 0.18*

Notes:

*

P-value as determined using Related Samples-Wilcoxon Signed Rank Test. All other P-values are from paired t-test analysis.